0001104659-22-100151.txt : 20220914 0001104659-22-100151.hdr.sgml : 20220914 20220914211617 ACCESSION NUMBER: 0001104659-22-100151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220914 DATE AS OF CHANGE: 20220914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULAT JAMES R CENTRAL INDEX KEY: 0001229448 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 221244328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 BUSINESS PHONE: 353 1 6960000 MAIL ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 4 1 tm2225913-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-16 0 0001567892 Mallinckrodt plc MNKPF 0001229448 SULAT JAMES R 675 MCDONNELL BLVD. HAZELWOOD MO 63042 1 0 0 0 Restricted Stock Units 2022-08-16 4 D 0 22533 0 D Ordinary Shares 22533 26276 D As previously disclosed, on August 16, 2022, James R. Sulat agreed to relinquish 22,533 of the restricted stock units ("RSUs") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the "MIP"). Mallinckrodt plc ("Mallinckrodt") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. Sulat 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014. /s/ Bryan M. Reasons, Attorney-in-Fact 2022-09-14